Abstract

Oral adenosquamous carcinoma (ASC) is a rare malignant neoplasm with both glandular and squamous differentiation and a tendency for aggressive clinical behavior. The tumor has a 13% to 50% survival rate after 5 years’ of treatment, with a predilection for men in the sixth or seventh decade of life. We report a case of a 63-year-old man with an ASC in the oral cavity. The tumor consisted of a hardened, painful, well-delimited mass in the dorsum of the tongue, extending through the oropharynx. The diagnostic hypotheses were epidermoid carcinoma, adenocarcinoma, or tuberculosis. An incisional biopsy was performed. The histopathologic analysis and the immunohistochemical reactions for CK7 and CK14 revealed a malignant neoplasm with adenocarcinomatous, glandular, and squamous components. After the diagnosis of an oral ASC, the patient was referred for appropriate medical management. The treatment consisted of chemotherapy, radiotherapy, and radical surgical resection, due to metastasis. The patient is under careful follow-up. Oral adenosquamous carcinoma (ASC) is a rare malignant neoplasm with both glandular and squamous differentiation and a tendency for aggressive clinical behavior. The tumor has a 13% to 50% survival rate after 5 years’ of treatment, with a predilection for men in the sixth or seventh decade of life. We report a case of a 63-year-old man with an ASC in the oral cavity. The tumor consisted of a hardened, painful, well-delimited mass in the dorsum of the tongue, extending through the oropharynx. The diagnostic hypotheses were epidermoid carcinoma, adenocarcinoma, or tuberculosis. An incisional biopsy was performed. The histopathologic analysis and the immunohistochemical reactions for CK7 and CK14 revealed a malignant neoplasm with adenocarcinomatous, glandular, and squamous components. After the diagnosis of an oral ASC, the patient was referred for appropriate medical management. The treatment consisted of chemotherapy, radiotherapy, and radical surgical resection, due to metastasis. The patient is under careful follow-up.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.